The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

As per The Business Research Company’s Noninvasive Prenatal Testing Global Market Report 2023, The global noninvasive prenatal testing market is expected to grow from $4.21 billion in 2022 to $4.84 billion in 2023 at a compound annual growth rate (CAGR) of 14.9%. The market size of the global non-invasive prenatal testing is expected to grow to $8.36 billion in 2027 at a CAGR of 14.7%.

What was the major driver in the noninvasive prenatal testing market?
High incidence rate of Down syndrome is one major factor driving non-invasive prenatal testing market with increase in average maternal age which has led to a concern on the safety about the growth of the fetus. Down syndrome is a chromosomal condition that occurs when an error in cell division results in an extra chromosome 21 and can affect the fetus cognitive ability and physical growth. The NIPT screening tests do not harm the mother or baby, carries no risk of miscarriage as they are non-invasive, and can detect more than 99% of cases of Down syndrome. According to National Down Syndrome Society and Centres for Disease control and Prevention, in the USA, 1 in every 700 babies are born with Down syndrome and 80% of children with Down syndrome are born to older mothers. The increased risk of having babies with Down syndrome among older women drives the growth of the non-invasive prenatal testing market.

View More On The Noninvasive Prenatal Testing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

What was the key trend in the noninvasive prenatal testing market?
Next-generation sequencing has increased the throughput, scalability, and speed, and further enables researchers to perform a wide range of applications and study biological systems at a higher level. Next-generation sequencing is a platform that has enabled the sequencing of thousands to millions of DNA molecules simultaneously. The manufacturers have introduced this technology to reduce the time and money required and optimizes the output to generate results regarding genome, and DNA testing. Major companies such as Illumina, Eurofins, Natera, Roche, and Annoroad have implemented this technology in non-invasive prenatal testing. CFDA (China Food and Drug Administration) has approved the medical instrument product registration of NGS instrument NextSeq 550AR produced by Annoroad.

Which was the largest region in the noninvasive prenatal testing market?
North America was the largest region in the non-invasive prenatal testing market in 2022. Western Europe was the second largest region in the global non-invasive prenatal testing market share. The regions covered in the global non-invasive prenatal testing market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Who are the noninvasive prenatal testing market prominent players?
Major players in the non-invasive prenatal testing market are F. Hoffmann-La Roche AG, IlluminaInc., Laboratory Corporation of America Holdings, NateraInc., PerkinElmerInc., Quest Diagnostics Incorporated, Agilent TechnologiesInc., BGI Diagnosis, Berry Genomics Co., Ltd., LifeCodexx AG, Myriad GeneticsInc., NIPD Genetics, SequenomInc., Annoroad Gene Technology, Centogene AG, CounsylInc., EUROFINS Genoma Group, Eurofins Scientific, Next Biosciences, Premaitha Health PLC., Ariosa Diagnostics (Roche), Premaitha Health, Beijing Genomics Institute, Yourgene Health PLC., GE Healthcare, Koninklijke Philips N.V., Thermo Fisher ScientificInc., Pacific Biosciences of CaliforniaInc., and QIAGEN N.V.

Key noninvasive prenatal testing market segments
The global noninvasive prenatal testing market is segmented –
1) By Type: Consumables, Instruments
2) By End User: Hospital, Diagnostic Labs
3) By Instruments: NGS Systems, PCR Instruments, Microarrays, Ultrasound Devices, Others(Centrifuges, UV Systems, Incubators, Microscopes)
4) By Consumables: Assay Kits &Reagents, Disposables
5) By Application: Trisomy, Microdeletion, Genetics, Rh factor

Request A Sample Of The Global Noninvasive Prenatal Testing Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smp

The Noninvasive Prenatal Testing Global Market Report 2023  provides a comprehensive overview on the noninvasive prenatal testing market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Prenatal Testing And Newborn Screening Global Market Report 2023
Testing, Inspection, And Certification Global Market Report 2023
Prenatal DNA Sequencing Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model